AP-778

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAP-778
Drug Alias NameThioacrylamide (ThAc) derivativesAP-778AP-0778
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 modulatorsGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptorPhosphodieterase 4
Therapy Area/IndicationsCognition DisordersDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlgiax Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAlgiax Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCognition DisordersDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A